Status:
UNKNOWN
Behçet's Disease Overall Damage Index
Lead Sponsor:
University of Cagliari
Conditions:
Behçet Disease
Behcet's Disease Aggravated
Eligibility:
All Genders
18+ years
Brief Summary
Damage in vasculitis, as well as in other chronic inflammatory disorders, accrues over time resulting in impairment of quality of life, development of disability and increased mortality. For these rea...
Detailed Description
DESIGN OF THE STUDY This observational multicenter study will be developed in 2 subsequent phases, in their turn, consisting of different steps (figure 1): 1. BODI Development 1.1) Development of a ...
Eligibility Criteria
Inclusion
- BD diagnosis according to ICBD criteria;
- disease duration ≥12 months;
- age at enrolment ≥ 18 years;
- Able to understand and voluntarily sign informed consent forms (ICFs) prior to the initiation of any study-specific assessments/procedures.
Exclusion
- unable to adhere to the protocol requirements.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT03803462
Start Date
August 1 2017
End Date
December 1 2019
Last Update
January 15 2019
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Rheumatology, Clinical Immunology and Allergy, University of Crete
Heraklion, Greece
2
Rheumatology Unit, University of Bari
Bari, Italy
3
Rheumatology Unit, Department of Clinical Sciences, AOU Sant'Anna University of Ferrara
Ferrara, Italy
4
Patient Association Delegates
Iglesias, Italy